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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S130ADAM and ADAMTS families of metalloproteinases their inhibitors the
TIMPs, all CCN growth factor family members, certain FGFs and
neuropeptide precursors and receptors in immortalised human chon-
drocytes, C28/I2.
Methods: We compared the response of C28/I2 cells cultured in
monolayer (2D) or on polyhema (3D; preventing cell adhesion to the
culture plastic) which is known to maintain chondrocyte phenotype,
exploring expression of 95 genes analysed by Taqman Low Density
Array. Ten genes showed signiﬁcant changes (p< 0.05) of at least 2-fold.
Results: In 2D cultures Interleukin 6 (IL6) was up-regulated 3-fold by
both bradykinin and Substance P. IL6 is up-regulated in OA joint ﬂuid
and elevated IL6 is associated with enhanced sensitivity to pain.
Although in 3D culture no signiﬁcant modulation of IL6 was observed
by neuropeptides we did observe up-regulation of IL6 expression in
response to IL1/Oncostatin M (used as a positive control). In 3D culture
expression of six genes was signiﬁcantly repressed (at least 2-fold) by
both bradykinin and substance P and no genes were signiﬁcantly
induced. Amongst these genes it was interesting to note suppression of
inhibitors TIMP2 (inhibitor of all MMPs) and TIMP3 (inhibits all MMPs,
certain ADAMs and ADAMTS proteinases). Expression of three metal-
loproteinases, ADAMTS9 (an aggrecanase), MMP2 and MMP15 was also
signiﬁcantly suppressed although expression of these enzymes was still
high. FGF18 was also suppressed by both neuropeptides in 3D only and
this growth factor has been shown to promote cartilage repair. WISP3/
CCN6 was repressed 2-fold in 3D culture by both neuropeptides. We
have previously demonstrated that WISP3/CCN6 is up-regulated in end
stage OA cartilage and regulates MMP and ADAMTS4 and 5 in chon-
drocytes. Whilst neurotrophin BDNF expression was repressed by both
neuropeptides, tachykinin 3 (the precursor to neurokinin B) was also
repressed fold by bradykinin but interestingly not by the tachykinin
substance P. We also explored expression of two of the genes regulated
in C28/I2 cells by qPCR analysis in primary human chondrocytes and
conﬁrmed that expression of both WISP3/CCN6 and TIMP3 was also
repressed by the two neuropeptides.
Conclusions: Overall our data suggest that the effects of substance P
and bradykinin on chondrocyte gene expression and matrix metabo-
lism are environment-dependent.235
LOCAL RAS IN THE HYPERTROPHIC DIFFERENTIATION OF
CHONDROCYTES
I. Tsukamoto y, M. Akagi y, S. Inoue y, Y. Oda y, T. Teramura z,
T. Takehara z, Y. Onodera z. yDept. of Orthopaedic Surgery, Faculty of
Med., Kinki Univ., Osaka-Sayama City, Japan; zDiv. of Cell Biology for
Regenerative Med., Kinki Univ., Osaka-Sayama City, Japan
Purpose: Recently, the local renin-angiotensin system (RAS) has
attracted many researchers in many pathophysiological issues. Also in
orthopedics, expression of the local RAS was found in fracture callus,
bone tissues and arthritic synovium. In the last year, we reported that
the local RAS expressed in chondrocytes of the epiphyseal plates of
mice. The purpose of this study is to reveal immunohistological local-
ization of the RAS components in the limb buds of mice where another
physiological hypertrophic differetiation occurs and to analyze function
of the local RAS in the processes of hypertrophic differentiation using
ATDC5 cell line.
Methods: The limb buds of 15-day-viviparous mice were immuno-
stained with antibodies to angiotensinogen, angiotensinogen convert-
ing enzyme 1 (ACE1), angiotensinII type 1 receptor (AT1R) and
angiotensinII type 2 receptor (AT2R). We cultured ATDC5 cell line and
evaluated expression of angiotensinogen, ACE1, AT1R and AT2R during
the hypertrophic term using quantitative real-time PCR and Western
blot analysis. Then, we separately stimulated AT1R and AT2R in
hypertrophic term using angiotensin II, olmesartan and PD123319 and
evaluated expression of type X collagen using quantitative real-time
PCR and Western blot analysis.
Results: In the limb buds of mice, angiotensinogen and AT1R
expressed in the resting chondrocytes, the proliferative chondrocytes
and hypertrophic chondrocytes; however, ACE1 and AT2R expressed
only in the hypertrophic chondrocytes. In ATDC5 cell line, angio-
tensinogen and AT1R expressed mainly in the proliferative term and
slightly in the hypertrophic term; conversely, ACE1 and AT2R
expressed mainly in the hypertrophic term and slightly in the prolif-
erating term. In the hypertrophic term, expression of type X collagenwere downregulated activating AT1R and were conversely upregu-
lated activating AT2R.
Conclusions: The local RAS also expresses in the limb buds of mice. In
the hypertrophic term of the chondrocyte differentiation, activating
AT1R decelerates the hypertrophic differentiation; conversely, acti-
vating AT2R accelerates the hypertrophic differentiation. Therefore,
the local RAS might regulate the chondrocyte hypertrophic differen-
tiation.236
PRONOUNCED DECREASE IN EXPRESSION OF CHONDROPROTECTIVE
SMAD2/3 PHOSPHORYLATING TGFb-SIGNALING RECEPTORS DURING
AGEING IN HEALTHY CARTILAGE
A. van Caam, E. Blaney Davidson, W. Madej, W. van den Berg, P. van der
Kraan. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, The Netherlands
Purpose: Osteoarthritis (OA) is a multi-factorial disease involving bone,
synovium and cartilage, with ageing as its key risk factor. Signaling by
the Transforming Growth Factor b (TGFb)-superfamily of ligands via
Smad phosphorylation (SmadP) plays a crucial role in cartilage
homeostasis, as Smad1/5/8p induces while Smad2/3p protects against
chondrocyte hypertrophy. In cartilage, age-related changes in expres-
sion of TGFb-superfamily members, like TGFb1 and BMP7, have been
observed. Furthermore, age-related changes in expression of the TGFb-
superfamily receptors ACVRL1 (ALK1) and TGFBRI (ALK5) are thought to
be involved in onset of OA. Based on these ﬁndings, we wanted to
investigate if gene expression of other members of the TGFb-super-
family signaling pathway changes during ageing in healthy cartilage.
Therefore, in this study we set out to identify age-related changes in
expression of TGFb-superfamily members and their receptors in normal
cartilage.
Methods: From the metacarpophalangeal joint of freshly butchered (<
3 h post mortem), cows (Bos Taurus) (n¼ 32, 7 male, 25 female), 28 mm2
full thickness cartilage explants were collected with a biopsy punch.
Age of the animals ranged from 1 up to 10 years, and samples were
evenly spread over this range. Macroscopically, none of the animals
showed any signs of OA. Samples were taken from the apical side of the
metacarpal chondyle medial to the intertrochlear notch, quickly
washed in saline to remove synovial ﬂuid, and ﬂash frozen in liquid
nitrogen. Cartilage was pulverized using a dismembrator and RNA was
extracted using the RNAeasy method. Gene expression was measured
by quantitative real time PCR, using cDNA speciﬁc primers and SYBR-
green. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used
as internal control. Regression analyses were done using SPSS.
Results: To assess the validity of the dataset, Collagen type 2 alpha 1
(Col2A1), and Tgfb1 , expression was measured, as expression of both
genes should decrease during ageing. Col2A1 expression decreased
4000-fold (R2 ¼ 0.85, p < 0.0001) fold, and Tgfb1 over 2 fold (R2 ¼ 0.35,
p¼ 0.0007) in a linear fashion between young and old animals, showing
that our dataset is valid for studying ageing of healthy cartilage .
Subsequently expression of TGFb-superfamily type I and type II recep-
tors was measured. Most notably, expression of all three Smad2/3
phosphorylating receptors, Acvr1b (ALK4) (R2 ¼ 0.36, p ¼ 0.0043),
Tgfbr1 (ALK5) (R2 ¼ 0.21, p ¼ 0.0077), and Acvr1c (ALK7) (R2 ¼ 0.26, p ¼
0.0317), was lowered by, on average, 4-fold during ageing, while of the
four Smad1/5/8 phosphorylating receptors only expression of Bmpr1a
(ALK3) (R2 ¼ 0.19, p ¼ 0.012) was lowered by 2-fold. Of the type II
receptors, only a decrease of approximately 3-fold in Bmpr2 (R2 ¼ 0.42,
p ¼ 0.0002) expression could be observed. No change in expression of
the two type III receptors Eng and Tgfbr3 was found. Furthermore no
changes in expression of the following members of the Transforming
Growth Factor b (TGFb)-superfamily: Tgfb2, Tgfb3, Bmp2, Bmp4, Gdf5 and
Bmp7 were observed.
Conclusions: Age-related changes previously observed in human and
murine cartilage could also be observed in bovine cartilage, showing the
validity of our dataset. We observed more changes in receptor expres-
sion than in growth factor (ligand) expression, suggesting a more
important role for change in receptor expression during the ageing
process compared to change in ligand expression. Strikingly, in our
dataset, expression of all three Smad2/3p phosphorylating receptors
was lowered during ageing, while expression of Smad1/5/8 phosphor-
ylating receptors remained largely unaffected. Given the importance of
Smad2/3p in maintaining articular cartilage phenotype, this can
underlie the increased responsiveness of aged chondrocytes to
processes that induce terminal differentiation.
